ArticleClinical case reports2025
Japanese Encephalitis Associated With Quadriplegia: The First Reported Case of Nepal.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Japanese Encephalitis Associated With Quadriplegia: The First Reported Case of Nepal.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japanese encephalitis (JE), a viral infection transmitted by Culex mosquitoes, primarily affects children and adolescents in endemic regions, with severe cases leading to life-threatening neurological complications. We report the first documented case of JE-associated quadriplegia in Nepal, involving a 19-year-old male presenting with high-grade fever, altered sensorium, vomiting, and profound motor dysfunction. Neurological examination confirmed quadriplegia, while cerebrospinal fluid analysis revealed mildly elevated protein and glucose levels, and brain imaging was unremarkable. Diagnosis was confirmed by serum JEV-specific IgM antibodies. The patient received supportive care, including hydration, antipyretics, prophylactic antibiotics, and corticosteroids, leading to significant motor function improvement over 2 weeks of hospitalization. This case presents the importance of early diagnosis, timely intervention, and rehabilitation in managing severe JE manifestations and highlights the critical need for adherence to national JE vaccination schedules to prevent such debilitating outcomes in endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.